Shanxi Meijin Energy fails in bid for Changjiang Pharma

Shanxi Meijin Energy Co., Ltd. (SZSE:000723) announced that its consortium, which included Sichuan Capital Market Relief and Development Securities Investment Fund Partnership (Limited Partnership), Jiakang (Shanghai) Consulting Co., Ltd., Zhejiang Oriental Star Investment Management Co., Ltd., and Beijing Zhonghan Oriental Technology Development Co., Ltd., was not chosen as a potential investor for the reorganization of Changjiang Pharmaceutical Holdings Co., Ltd. The decision was made following a review by the investor selection committee. The company's initial proposal to participate in the public solicitation of investors for Changjiang Pharmaceutical Holdings, including its investment plan, was previously disclosed in an announcement (No. 2025-020) on the Shenzhen Stock Exchange's website.